Talon Therapeutics (NASDAQOTCBB:TLON)
CAPS Rating:
A development stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care.
A development stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care.
Recs
this stock has been diluted with warrants & preferreds